数字化正畸市场
数字化正畸市场：2026年市场规模约为49.4亿美元，2031年市场规模约为77.9亿美元；预测期复合年增长率为9.53%；当前最大市场为北美；增长最快的市场为亚太地区。
市场研究正文
规模、增长、细分、驱动因素与关键问题
当前质量分 100.00，审核状态 accepted。结构化字段已按 RoboInd 内容层级组织。
核心结论
数字化正畸市场：2026年市场规模约为49.4亿美元，2031年市场规模约为77.9亿美元；预测期复合年增长率为9.53%；当前最大市场为北美；增长最快的市场为亚太地区。
市场走势
结构化指标
| 指标 | 年份 | 数值 | 性质 |
|---|---|---|---|
| 复合年增长率 | 2031 | 9.53% | 机构预测 |
| 市场规模 | 2026 | USD 4.94 billion | 机构预测 |
| 市场规模 | 2031 | USD 7.79 billion | 机构预测 |
细分市场份额
市场结构
| 维度 | 细分项 | 年份 | 份额 |
|---|---|---|---|
| end_user | orthodontic clinics | 2025 | 53.240% |
| geography | North America | 2025 | 39.560% |
| patient_group | adults | 2025 | 56.760% |
| product_type | clear aligners | 2025 | 49.880% |
| technology | optical intraoral scanning | 2025 | 34.550% |
关键结论
- end_user 维度中，orthodontic clinics 在 2025 年的公开份额为 53.24%。
- geography 维度中，North America 在 2025 年的公开份额为 39.56%。
- patient_group 维度中，adults 在 2025 年的公开份额为 56.76%。
- product_type 维度中，clear aligners 在 2025 年的公开份额为 49.88%。
- technology 维度中，optical intraoral scanning 在 2025 年的公开份额为 34.55%。
主要参与者
- Align Technology, Inc.
- DENTSPLY SIRONA Inc.
- Henry Schein, Inc.
- Institut Straumann AG
- Ormco Corporation
增长驱动因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Clear aligner treatment adoption | +3.200% | Global, with the highest velocity in North America and East Asia | Medium term (2-4 years) |
| Intraoral scanner penetration | +2.100% | North America and Europe are at the core, with Asia-Pacific emerging | Short term (≤ 2 years) |
| Faster and more comfortable digital impressions | +1.000% | Global | Short term (≤ 2 years) |
| In-office and direct 3D-printed appliance production | +0.900% | North America, Europe, and the core Asia-Pacific markets | Medium term (2-4 years) |
| Reusable patient data across workflows | +0.600% | Global, with early gains in digitally mature markets | Long term (≥ 4 years) |
| Ai-assisted detection and treatment simulation | +1.200% | Global, initially concentrated in North America and Europe | Medium term (2-4 years) |
市场制约因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Cost of scanners, software, and 3D printing infrastructure | -1.100% | Emerging markets and solo practices in mid-tier cities globally | Medium term (2-4 years) |
| Training needs and uneven digital competence | -0.600% | Global, with greater pressure in South and Southeast Asia and Sub-Saharan Africa | Long term (≥ 4 years) |
| Limited predictability for complex tooth movement | -0.400% | Global | Medium term (2-4 years) |
| Material validation, data governance, and interoperability risks | -0.500% | Europe and North America, where compliance needs are intensive | Long term (≥ 4 years) |
报告关注的关键问题
What is driving growth in digital pills?
Objective medication records, decentralized research, regulatory clarity, and remote chronic-care use support adoption. The Digital pills market is forecast to grow at a 12.45% CAGR from 2026 to 2031.
Which digital pill product type has the largest share?
Capsules held 61.40% of revenue in 2025. Their position is supported by capsule endoscopy and the ability to add sensors around existing formulations.
What is the fastest-growing application for digital pills?
Patient monitoring is forecast to grow at a 14.51% CAGR through 2031. The application includes gastrointestinal monitoring as well as ingestion-related information.
Which end users are adopting digital pill systems most quickly?
Clinics are forecast to grow at a 14.55% CAGR through 2031. Their model can fit ambulatory chronic-care programs when pharmacy and care-team processes are in place.
Which region is growing fastest for digital pills?
Asia-Pacific is forecast to grow at a 15.20% CAGR through 2031. Regulatory modernization and expanding diagnostic infrastructure support its outlook.
What limits wider use of ingestible sensor systems?
Added treatment costs, uneven reimbursement, data reliability concerns, consent requirements, and workflow demands can limit adoption.
市场概览
- 增长最快市场：亚太地区
- 最大市场：北美
- 市场集中度：中等
查看来源：Mordor Intelligence